A federal court ordered a Texas-based company to stop producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act).
from FDA Press Releases RSS Feed http://bit.ly/2JXxf5J
via IFTTT
No comments:
Post a Comment